216 related articles for article (PubMed ID: 28856398)
1. Association of use of selective serotonin reuptake inhibitors with risk of acute pancreatitis: a case-control study in Taiwan.
Lin HF; Liao KF; Chang CM; Lin CL; Lai SW
Eur J Clin Pharmacol; 2017 Dec; 73(12):1615-1621. PubMed ID: 28856398
[TBL] [Abstract][Full Text] [Related]
2. Use of Selective Serotonin Reuptake Inhibitors and Risk of Hip Fracture in the Elderly: A Case-Control Study in Taiwan.
Hung SC; Lin CH; Hung HC; Lin CL; Lai SW
J Am Med Dir Assoc; 2017 Apr; 18(4):350-354. PubMed ID: 28159466
[TBL] [Abstract][Full Text] [Related]
3. Selective serotonin reuptake inhibitors and risk of acute pancreatitis: a population-based case-control study.
Nørgaard M; Jacobsen J; Gasse C; Pedersen L; Mortensen PB; Sørensen HT
J Clin Psychopharmacol; 2007 Jun; 27(3):259-62. PubMed ID: 17502772
[TBL] [Abstract][Full Text] [Related]
4. Selective serotonin reuptake inhibitors and the risk of acute pancreatitis: a Swedish population-based case-control study.
Ljung R; Rück C; Mattsson F; Bexelius TS; Lagergren J; Lindblad M
J Clin Psychopharmacol; 2012 Jun; 32(3):336-40. PubMed ID: 22544014
[TBL] [Abstract][Full Text] [Related]
5. Atorvastatin Use Associated With Acute Pancreatitis: A Case-Control Study in Taiwan.
Lai SW; Lin CL; Liao KF
Medicine (Baltimore); 2016 Feb; 95(7):e2545. PubMed ID: 26886597
[TBL] [Abstract][Full Text] [Related]
6. Association of Selective Serotonin Reuptake Inhibitor Use and Acute Angle-Closure Glaucoma.
Chen HY; Lin CL; Lai SW; Kao CH
J Clin Psychiatry; 2016 Jun; 77(6):e692-6. PubMed ID: 27135704
[TBL] [Abstract][Full Text] [Related]
7. Use of Simvastatin and Risk of Acute Pancreatitis: A Nationwide Case-Control Study in Taiwan.
Lin CM; Liao KF; Lin CL; Lai SW
J Clin Pharmacol; 2017 Jul; 57(7):918-923. PubMed ID: 28301063
[TBL] [Abstract][Full Text] [Related]
8. Effects of selective serotonin reuptake inhibitors on glaucoma: A nationwide population-based study.
Chen VC; Ng MH; Chiu WC; McIntyre RS; Lee Y; Lin TY; Weng JC; Chen PC; Hsu CY
PLoS One; 2017; 12(3):e0173005. PubMed ID: 28257449
[TBL] [Abstract][Full Text] [Related]
9. Investigation of the potential association between the use of fluoxetine and occurrence of acute pancreatitis: a Danish register-based cohort study.
Aakjær M; Kristiansen SB; Pape K; Sessa M; Dalhoff KP; De Bruin ML; Andersen M
Int J Epidemiol; 2022 Oct; 51(5):1656-1665. PubMed ID: 35472246
[TBL] [Abstract][Full Text] [Related]
10. Sitagliptin use and risk of acute pancreatitis in type 2 diabetes mellitus: A population-based case-control study in Taiwan.
Liao KF; Lin CL; Lai SW; Chen WC
Eur J Intern Med; 2016 Jan; 27():76-9. PubMed ID: 26433909
[TBL] [Abstract][Full Text] [Related]
11. Current use of selective serotonin reuptake inhibitors and risk of acute myocardial infarction.
Schlienger RG; Fischer LM; Jick H; Meier CR
Drug Saf; 2004; 27(14):1157-65. PubMed ID: 15554748
[TBL] [Abstract][Full Text] [Related]
12. Selective serotonin reuptake inhibitors and the risk of stroke: a population-based case-control study.
Bak S; Tsiropoulos I; Kjaersgaard JO; Andersen M; Mellerup E; Hallas J; García Rodríguez LA; Christensen K; Gaist D
Stroke; 2002 Jun; 33(6):1465-73. PubMed ID: 12052976
[TBL] [Abstract][Full Text] [Related]
13. [Selective serotonin uptake inhibitors and pancreatitis].
Kvande KT; Madsen S
Tidsskr Nor Laegeforen; 2001 Jan; 121(2):177-8. PubMed ID: 11475194
[TBL] [Abstract][Full Text] [Related]
14. Intracerebral Hemorrhage and Outcome After Thrombolysis in Stroke Patients Using Selective Serotonin-Reuptake Inhibitors.
Scheitz JF; Turc G; Kujala L; Polymeris AA; Heldner MR; Zonneveld TP; Erdur H; Curtze S; Traenka C; Brenière C; Wiest R; Rocco A; Sibolt G; Gensicke H; Endres M; Martinez-Majander N; Béjot Y; Nederkoorn PJ; Oppenheim C; Arnold M; Engelter ST; Strbian D; Nolte CH;
Stroke; 2017 Dec; 48(12):3239-3244. PubMed ID: 29127269
[TBL] [Abstract][Full Text] [Related]
15. Fluvastatin use and risk of acute pancreatitis: a population-based case-control study in Taiwan.
Liao KF; Huang PT; Lin CC; Lin CL; Lai SW
Biomedicine (Taipei); 2017 Sep; 7(3):17. PubMed ID: 28840831
[TBL] [Abstract][Full Text] [Related]
16. Dose of selective serotonin reuptake inhibitors and risk of upper gastrointestinal bleeding in older adults.
Li YH; Hang LW; Muo CH; Chen SJ; Chen PC
J Psychopharmacol; 2024 Feb; 38(2):137-144. PubMed ID: 38126253
[TBL] [Abstract][Full Text] [Related]
17. Use of selective serotonin reuptake inhibitors and risk of developing first-time acute myocardial infarction.
Meier CR; Schlienger RG; Jick H
Br J Clin Pharmacol; 2001 Aug; 52(2):179-84. PubMed ID: 11488775
[TBL] [Abstract][Full Text] [Related]
18. Use of SSRI, But Not SNRI, Increased Upper and Lower Gastrointestinal Bleeding: A Nationwide Population-Based Cohort Study in Taiwan.
Cheng YL; Hu HY; Lin XH; Luo JC; Peng YL; Hou MC; Lin HC; Lee FY
Medicine (Baltimore); 2015 Nov; 94(46):e2022. PubMed ID: 26579809
[TBL] [Abstract][Full Text] [Related]
19. Rosuvastatin and risk of acute pancreatitis in a population-based case-control study.
Lai SW; Lin CL; Liao KF
Int J Cardiol; 2015; 187():417-20. PubMed ID: 25841139
[TBL] [Abstract][Full Text] [Related]
20. A population-based case-control study of Selective Serotonin Reuptake Inhibitors (SSRIs) and breast cancer: the impact of duration of use, cumulative dose and latency.
Ashbury JE; Lévesque LE; Beck PA; Aronson KJ
BMC Med; 2010 Dec; 8():90. PubMed ID: 21176215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
